The impact of current trends in biotech and healthcare on national and European R&D grants

With biotech identified as a critical technology to boost Europe’s competitiveness, now is a prime time for biotech companies to seize new funding opportunities. However, significant challenges persist, such as transitioning from research to market and navigating regulatory complexities. To help overcome these hurdles, the R&D funding landscape is evolving rapidly. Key developments are shaping funding strategies, including cross-border sharing of health data, sustainable healthcare systems, reduced carbon footprints, impact-driven investments, and the integration of AI in healthcare.